LifeMD vs Noom
LifeMD costs $50 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
LifeMD
Best for: bloodwork inside the monthly price rather than billed on top
Visit LifeMD →
If you are choosing between LifeMD and Noom, the first difference is cost: LifeMD is $50 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. LifeMD leads our six-part score, 7.9 to 6.7.
LifeMD vs Noom price
LifeMD is the cheaper way in: $149 a month against $199 a month at Noom. That is $50 less each month (25% lower), or about $600 over a year of treatment.
Drug by drug: Semaglutide is cheaper at LifeMD ($149 a month vs $199 a month); tirzepatide costs the same at both, $349 a month.
Medications and formats
Both sell semaglutide and tirzepatide.
On format, LifeMD prices brand-name pens, while Noom prices brand-name pens and compounded injections.
Where each one treats patients
LifeMD lists 50 states, and Noom does not publish where it ships.
Pricing
LifeMD
First month $75, then $149/mo. Brand medication billed separately, or $0-$25/mo copay with commercial insurance.
Medication only; plus the $149/mo program fee.
Medication only (starting); plus the program fee. As low as $0-$25/mo with insurance.
Medication only; plus the $149/mo program fee.
Noom
What each price covers
Both prices cover the clinician visit and coaching.
LifeMD's price also covers lab work, which Noom does not claim.
LifeMD is silent on shipping.
Noom is silent on the medication itself, shipping and lab work.
LifeMD
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, LifeMD scores 7.9 and Noom 6.7 out of 10.
LifeMD is stronger on value (10.0 vs 4.4), accessibility (10.0 vs 5.0) and support (5.5 vs 4.0).
Noom is stronger on user experience (8.0 vs 3.0) and trust & safety (6.5 vs 6.0).
Effectiveness is within half a point.
LifeMD
7.9/10
Noom
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither LifeMD nor Noom has an FDA warning letter on record with us.
Features & Coverage
| Feature | LifeMD | Noom |
|---|---|---|
| Starting Price | ✓$149/mo | $199/mo |
| Features | 0 features | ✓2 features |
| States Available | 50 | Not disclosed |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About LifeMD
LifeMD is a publicly traded telehealth seller. It carries brand-name GLP-1 medications only.
Read our full LifeMD review →About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →Pros & Cons
LifeMD
What we like
- Semaglutide costs $149 a month, 85% below the $990 median for brand-name semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- The monthly price includes clinician visits, lab work and coaching
- Serves all 50 states
- We found no FDA warning letters issued to LifeMD
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Not included in the monthly price: medication
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Noom
What we like
- Semaglutide costs $199 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
LifeMD wins this one, 7.9 to 6.7, above all for bloodwork inside the monthly price rather than billed on top. It also costs $50 less each month than Noom. Noom fits better if coaching bundled into the price rather than sold separately is your priority.
Choose LifeMD if…
You want bloodwork inside the monthly price rather than billed on top and an opening price near $149 a month.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →LifeMD vs Noom: FAQ
Close alternatives to LifeMD and Noom
- LifeMD vs altRX
- LifeMD vs Gala
- LifeMD vs Sprout Health
- LifeMD vs Aquivia Health
- Noom vs Hims
- Noom vs Hers
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.